Philipp Nuhn

Title: Innovations in Cancer Treatment by Inventor Philipp Nuhn

Introduction

Philipp Nuhn is a notable inventor based in Baltimore, MD (US), recognized for his contributions to cancer treatment through innovative methodologies. He holds 2 patents that focus on the induction of synthetic lethality with epigenetic therapy, showcasing his commitment to advancing medical science.

Latest Patents

Nuhn's latest patents revolve around the induction of synthetic lethality with epigenetic therapy. The disclosures relate to compositions and methods for treating cancer. These methods utilize a combination of at least one epigenetic compound and at least one chemotherapeutic agent. Additionally, the patents include screening methods for identifying compounds that can effectively kill cancer cells when combined with epigenetic compounds. Furthermore, they describe methods for enhancing the therapeutic effects of chemotherapeutic agents against cancer by administering epigenetic compounds in effective amounts.

Career Highlights

Philipp Nuhn is affiliated with The Johns Hopkins University, where he contributes to groundbreaking research in cancer therapies. His work is pivotal in exploring new avenues for cancer treatment, particularly through the lens of epigenetics.

Collaborations

Nuhn collaborates with esteemed colleagues such as Srinivasan Yegnasubramanian and William G Nelson, who share his vision for innovative cancer therapies.

Conclusion

Philipp Nuhn's work exemplifies the intersection of innovation and medical research, particularly in the field of cancer treatment. His patents and collaborations reflect a dedication to improving therapeutic outcomes for patients.